Search
Palvella Therapeutics Inc
PVLAAdd to Watchlist
139.040USD
-11.150-7.42%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.99BMarket Cap
LossP/E TTM
Palvella Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Palvella Therapeutics Inc is 9.28, ranking 23 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -33.35, which is -99.11% below the recent high of -0.30 and -77.03% above the recent low of -59.04.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.